Money Concepts Capital Corp Madrigal Pharmaceuticals, Inc. Transaction History

Money Concepts Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$231.06 - $307.08 $307,078 - $408,109	1,329 Added 68.9%	3,258 $789,000
Q3 2022 Oct 27, 2022	BUY	$60.57 - $79.51 $116,839 - $153,374	1,929 New	1,929 $125,000
Q2 2022 Jul 18, 2022	SELL	$58.04 - $100.2 $2,147 - $3,707	-37 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $2,067 - $3,769	37 New	37 $4,000

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.37B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.